Rezvilutamide: all 22 studies that test it
Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical ProstatectomyRecruitingNCT07711314Phase 2
- Rezvilutamide for High-Risk Prostate Cancer After SurgeryNot yet recruitingNCT07444983Not applicable
- A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate CancerRecruitingNCT07241416Phase 3
- Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct CarcinomaRecruitingNCT06348264Phase 2
- Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate CancerRecruitingNCT06305832Phase 2
- Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate CancerNot yet recruitingNCT06134271Phase 2
- Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPCRecruitingNCT05956639Phase 3
- A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer SubjectsRecruitingNCT05607693Phase 1
- Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate CancerRecruitingNCT05406999Phase 2
- A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular TypingActive, not recruitingNCT05924256Phase 2
- A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical ProstatectomyTerminatedNCT05009290Phase 3
- The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and OmeprazoleCompletedNCT04676035Phase 1
- Drug-drug Interaction of SHR3680 With Repaglinide and BupropionStatus unknownNCT04664725Phase 1
- An Investigational Study of SHR3680 in Participants With Mild to Moderate Liver Impairment and Healthy ParticipantsStatus unknownNCT04631549Phase 1
- Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin HydrochlorideCompletedNCT04621669Phase 1
- A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPCStatus unknownNCT04603833Phase 2
- Molecularly Targeted Umbrella Study in Luminal Advanced Breast CancerStatus unknownNCT04355858Phase 2
- A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPCTerminatedNCT04102124Phase 2
- A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPCTerminatedNCT03741712Phase 1/2
- A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate CancerActive, not recruitingNCT03520478Phase 3
- A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate CancerCompletedNCT02747342Phase 1
- A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer PatientsStatus unknownNCT02691975Phase 1/2